atrasentan has been researched along with pd 156707 in 1 studies
| Studies (atrasentan) | Trials (atrasentan) | Recent Studies (post-2010) (atrasentan) | Studies (pd 156707) | Trials (pd 156707) | Recent Studies (post-2010) (pd 156707) |
|---|---|---|---|---|---|
| 358 | 41 | 108 | 11 | 0 | 4 |
| Protein | Taxonomy | atrasentan (IC50) | pd 156707 (IC50) |
|---|---|---|---|
| Endothelin receptor type B | Homo sapiens (human) | 0.417 | |
| Endothelin-1 receptor | Homo sapiens (human) | 0.0003 | |
| Endothelin receptor type B | Sus scrofa (pig) | 0.34 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anzali, S; Christadler, M; Dorsch, D; Fluck, M; Mederski, WW; Osswald, M; Schelling, P; Schmitges, CJ; Wilm, C | 1 |
1 other study(ies) available for atrasentan and pd 156707
| Article | Year |
|---|---|
Endothelin antagonists: discovery of EMD 122946, a highly potent and orally active ETA selective antagonist.
Topics: Animals; Biological Availability; Blood Pressure; Endothelin Receptor Antagonists; Endothelin-1; Rats; Receptor, Endothelin A; Swine; Thiazoles | 1998 |